The aim of this article was to determine whether CSF PDGFRβ is indeed associated with aging and key AD pathologic changes (measured with Aβ-PET and tau-PET) and APOE ε4 genotype in the deeply phenotyped BioFINDER-2 cohort. This evidence concerns the gene PDGFRB and Alzheimer disease.